Department of Clinical Research
Employment upon agreement
The Faculty of Medicine at the University of Bern is an environment for high-quality, future-oriented research. Strong connections between basic research, engineering sciences, and university hospitals enable a unique setting for translational and patient-centered clinical research. The faculty prioritizes cross-disciplinary research and digitalization, fostering innovation in medical science. It is one of the largest medical faculties in Switzerland and is affiliated with the country's largest hospital complex.
The Department of Clinical Research (DCR) is a joint initiative of the University of Bern's Faculty of Medicine and its university hospitals, including Inselspital and the University Psychiatric Services (UPD). It supports and professionalizes clinical and translational research collaborations.
Our specialized divisions assist researchers throughout the entire research process, from project conception to result dissemination. We provide tailored educational programs and events on all aspects of clinical research, equipping researchers and students with the skills to conduct efficient and impactful studies. Our mission prioritizes patient-centered research, ensuring that patient perspectives are integral to our work.
The Medical Data Science group, led by Assistant Professor Benjamin Ineichen, a medical doctor with a PhD in neuroscience/pharmacology, is part of the DCR at the University of Bern. The group, known as the STRIDE-Lab, is a multidisciplinary team with expertise in medicine, neuroscience, statistics, and computer science. It focuses on bridging the gap between preclinical and clinical research and eventually drug approval, to advance therapy development for human diseases, with a focus on neuroscience. Using evidence synthesis and data science, the lab aims to improve experimental animal welfare while also contributing to better patient treatments.
Tasks
Developing drugs for clinical applications is challenging, with only about 5% of therapies receiving regulatory approval (Ineichen et al., PLoS Biology, 2024). While some failures are due to the complexity of innovative therapies, others stem from adjustable factors in drug testing, such as outcome measures, trial duration, and model selection (Berg et al., eBiomedicine, 2024). The impact of these factors is difficult to assess in individual trials but can be uncovered through large-scale clinical trial data analysis (Ineichen et al., Nature Reviews, 2024).
Our approach combines expertise in medicine, evidence synthesis, and natural language processing (NLP) (Doneva et al., EMNLP, 2024) with Bern's extensive clinical trial landscape and modern data science infrastructure. The goal is to identify the key factors driving successful drug approvals and use this knowledge to optimize clinical trial design. This shall be achieved by developing
MNCJobs.ch will not be responsible for any payment made to a third-party. All Terms of Use are applicable.